Sweeney & Michel’s Amgen AMGN Stock Holding History

Sweeney & Michel’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.78M	Buy	5,082 +20	+0.4%	+$7.13K	0.52%	36
2025 Q4	$1.86M	Sell	5,062 -7	-0.1%	-$2.22K	0.55%	33
2025 Q3	$1.47M	Buy	5,069 +70	+1%	+$20.3K	0.49%	37
2025 Q2	$1.48M	Sell	4,999 -191	-4%	-$54.1K	0.52%	36
2025 Q1	$1.45M	Buy	+5,190	New	+$1.53M	0.64%	31
2024 Q3	$1.63M	Buy	5,067 +23	+0.5%	+$7.52K	0.64%	29
2024 Q2	$1.59M	Buy	5,044 +24	+0.5%	+$7.05K	0.68%	27
2024 Q1	$1.56M	Buy	+5,020	New	+$1.47M	0.69%	26
2023 Q3	$1.45M	Buy	5,291 +30	+0.6%	+$7.49K	0.76%	25
2023 Q2	$1.37M	Buy	5,261 +33	+0.6%	+$7.66K	0.71%	24
2023 Q1	$1.16M	Buy	+5,228	New	+$1.28M	0.62%	28

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Sweeney & Michel's AMGN Position: Q1 2026 in Review

Sweeney & Michel increased its Amgen (AMGN) stake by 0.4% in Q1 2026, buying an estimated $7.13K and bringing the position to 5,082 shares worth $1.78M. The position accounts for 0.52% of the portfolio, ranked #36.

Sweeney & Michel first reported a position in AMGN in Q1 2023 and has held it in 11 quarters since. The position peaked at $1.86M in Q4 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Sweeney & Michel held 5,082 shares of Amgen worth $1.78M as of Q1 2026.
Sweeney & Michel bought 20 Amgen shares in Q1 2026, an estimated $7.13K.
Amgen made up 0.52% of Sweeney & Michel's portfolio in Q1 2026, its #36 holding.
Sweeney & Michel first reported a position in Amgen in Q1 2023 and has held it in 11 quarters since.
Sweeney & Michel's Amgen position peaked at $1.86M in Q4 2025.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Sweeney & Michel's 13F filing for Q1 2026, filed 16 Apr 2026.